Actinogen Medical Limited
ATGGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17 | $23 | $9 | $11 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $6 | $0 | $9 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $22 | $23 | $19 | $12 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $2 | $2 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $24 | $25 | $21 | $14 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $2 |
| Short-Term Debt | $3 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $0 | $1 | $0 |
| Total Curr. Liab. | $6 | $1 | $1 | $2 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $6 | $1 | $2 | $2 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $101 | $120 | $100 | $96 |
| Retained Earnings | -$96 | -$90 | -$82 | -$80 |
| AOCI | $14 | $13 | $1 | -$4 |
| Other Equity | $0 | -$19 | $0 | $0 |
| Total Equity | $18 | $24 | $20 | $12 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $24 | $25 | $21 | $14 |
| Net Debt | -$13 | -$23 | -$9 | -$11 |